DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor next 10-Q for guidance revision
Final — all horizons settled through T+60d
STOK ▼ -20.76% at T+60d
NEUTRAL call ✗ call lost -20.76% · α vs SPY -25.77% · entry $34.93 → $27.68
T+1d
-2.58%
call -2.58% · α -3.36%
$34.03
settled 5mo ago
T+5d
-7.19%
call -7.19% · α -8.66%
$32.42
settled 5mo ago
T+20d
-13.27%
call -13.27% · α -17.90%
$30.30
settled 5mo ago
T+60d
-20.76%
call -20.76% · α -25.77%
$27.68
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Stoke Therapeutics' 2026 proxy statement details the election of three Class I directors, ratification of auditors, and advisory approval of executive compensation. This filing is routine governance material, routine for a biotech company.
Key Facts
- Election of Class I directors: G. Clare Kahn, Ph.D., Adrian Krainer, Ph.D., and Julie Anne Smith
- Ratification of Ernst & Young LLP as independent auditors for fiscal year 2026
- Advisory vote on executive compensation
Financial Impact
Routine governance matters with no immediate financial impact
governanceexecutive compensation
Risk Factors
- Potential for shareholder dissent on executive compensation
- Board composition changes could affect strategic direction
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-170393 |
| Document: 0001193125-26-170393-index-headers.html | 0001193125-26-170393 |
| Document: 0001193125-26-170393-index.html | 0001193125-26-170393 |
| Document: 0001193125-26-170393.txt | 0001193125-26-170393 |
9 reports for STOK
75% Hit rate best @ T+60▲ +12.62%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 19, 2026 6w ago | Insider Cluster | $33.03 $28.93 | ▼ −12.41% | ▼ −10.46% | $25.91 (−21.56%) |
Aug 3, 2026 8w ago | 8-K | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.91 (+18.19%) |
Aug 3, 2026 8w ago | 424B5 | $31.67 $30.89 | ▲ +2.46% | ▲ +1.22% | $25.91 (+18.19%) |
Jun 30, 2026 13w ago | 8-K | $32.72 $29.31 | ▼ −10.42% | ▼ −9.39% | $25.91 (−20.82%) |
May 7, 2026 21w ago | 8-K | $32.89 $30.01 | ▼ −8.76% | ▼ −8.78% | $25.91 (−21.23%) |
Apr 22, 2026 23w ago | DEFA14A | $34.93 $30.30 | ▼ −13.27% | ▼ −17.90% | $25.91 (−25.83%) |
Apr 7, 2026 25w ago | 8-K | $34.87 $32.96 | ▼ −5.48% | ▼ −14.02% | $25.91 (−25.70%) |
Mar 13, 2026 29w ago | Insider Cluster | $33.19 $35.05 | ▼ −5.60% | ▼ −2.02% | $25.91 (+21.94%) |
Mar 10, 2026 29w ago | Insider Cluster | $38.35 $34.87 | ▼ −9.07% | ▼ −8.92% | $25.91 (−32.44%) |
Showing 9 of 9
US Market Status
Market Open — Closes in 3h 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access